Publication:
Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?

dc.contributor.coauthorAfşar, Barış
dc.contributor.coauthorTakir, Mümtaz
dc.contributor.coauthorKöstek, Osman
dc.contributor.coauthorCovic, Adrian
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-10T00:06:24Z
dc.date.issued2014
dc.description.abstractRecently, endocanformerly known as endothelial cell-specific molecule 1 (ESM-1)was found to be associated with entities such as cancer, hypertension, renal transplant rejection, and chronic renal failure. Endothelial cells of many organs secrete endocan, but the exact functions of this relatively new molecule have not been elucidated completely. Emerging evidence suggests, however, that endocan plays an important role in inflammation, upregulation of cell adhesion molecules, lymphocyte functions, and endothelial cytoskeleton rearrangement. As suggested above, endocan has a prognostic impact in hypertension, transplant rejection, and chronic renal failure. In the current review, the evidence regarding endocan, hypertension, and chronic renal failure are summarized.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue12
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume16
dc.identifier.doi10.1111/jch.12440
dc.identifier.eissn1751-7176
dc.identifier.issn1524-6175
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-84919642444
dc.identifier.urihttps://doi.org/10.1111/jch.12440
dc.identifier.urihttps://hdl.handle.net/20.500.14288/16600
dc.identifier.wos346466900013
dc.keywordsCell-Specific Molecule-1
dc.keywordsExpression
dc.keywordsMarker
dc.keywordsESM-1
dc.keywordsLung
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofJournal of Clinical Hypertension
dc.subjectPeripheral vascular disease
dc.titleEndocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files